Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Sales | 7,032 | 30,853 | 10,043 | 8,593 | 9,387 |
| Gross Profit | 7,032 | 30,853 | 10,043 | 8,593 | 9,387 |
| Operating Expenses | 29,728 | 29,306 | 24,593 | 24,248 | 24,979 |
| Operating Income | -22,696 | 1,547 | -14,550 | -15,655 | -15,592 |
| Interest Expense | 0 | 0 | 0 | 28 | 70 |
| Other Income | 4,778 | 4,516 | 2,828 | 2,527 | 2,396 |
| Pre-tax Income | -17,918 | 6,063 | -11,722 | -13,156 | -13,266 |
| Net Income Continuous | -17,918 | 5,960 | -11,722 | -13,156 | -13,266 |
| Net Income | $-17,918 | $5,960 | $-11,722 | $-13,156 | $-13,266 |
| EPS Basic Total Ops | -0.28 | 0.15 | -0.24 | -0.27 | -0.28 |
| EPS Basic Continuous Ops | -0.28 | 0.15 | -0.24 | -0.27 | -0.28 |
| EPS Diluted Total Ops | -0.28 | 0.15 | -0.24 | -0.27 | -0.28 |
| EPS Diluted Continuous Ops | -0.28 | 0.15 | -0.24 | -0.27 | -0.28 |
| EPS Diluted Before Non-Recurring Items | -0.28 | 0.15 | -0.24 | -0.27 | -0.28 |
| EBITDA(a) | $-25,283 | $-866 | $-16,497 | $-17,192 | $-17,170 |